Skip to main content
NIVF
NASDAQ Industrial Applications And Services

NewGenIvf Closes $1.25M Offering at $0.07/Share — 17.9M Shares/Warrants Issued

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.162
Mkt Cap
$162.416K
52W Low
$0.064
52W High
$1,539
52W Position info
154% above low
Off High info
100% below high
Rel. Volume info
57× avg
Market data snapshot near publication time

NIVF has more than doubled off its 52-week low of $0.064 on elevated volume (57× avg).

Summary

A $1.25M offering at $0.07/share has been closed, issuing 17.9M shares and pre-funded warrants — a deeply dilutive raise to fund K25.ai, debt restructuring, and cell-sorting operations.


Key Events · Financing and Capital Events · NIVF

  • Offering Closed at $0.07/Share

    On September 30, 2026, a $1.25M best-efforts offering was closed, issuing 125,000 Class A ordinary shares and pre-funded warrants to purchase up to 17,732,143 additional shares at $0.07 per share.

  • Deeply Dilutive Pricing

    The $0.07 offering price is a steep discount to the $0.1615 market price at the time of this report, resulting in significant dilution for existing shareholders.

  • Use of Proceeds

    Net proceeds will fund investment in K25.ai, restructuring of debt securities, working capital for Nodexus machine manufacturing and deployment, and general corporate purposes.

  • Placement Agent Terms

    Aegis Capital Corp. received an 8.0% cash fee on gross proceeds plus expense reimbursement, with a 12-month right of first refusal on future financings.


Analysis · NIVF · Industrial Applications And Services

A $1.25 million best-efforts offering at $0.07 per share has been closed, issuing 17.9 million Class A ordinary shares and pre-funded warrants. The deal was priced at a deep discount to the market, adding substantial dilution to existing holders. Proceeds are earmarked for K25.ai investment, debt restructuring, and working capital for the Nodexus cell-sorting business. The 8% placement fee to Aegis Capital and 60-day lock-ups on insiders are standard terms, but the pricing level reflects the company's constrained access to capital.

How filings like this one have moved

In the 30 days to Sep 30, 2026, 34.9% of the 1009 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NIVF was trading at $0.16 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $162.4K. The 52-week trading range was $0.06 to $1,539.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NIVF - Latest Insights

NIVF
Sep 30, 2026, 8:45 AM EDT
Filing Type: 424B4
Importance Score:
9
Price at Filing: $0.1505
Real-time Price: $0.1403 info
Change: -$0.0102 (-7%) info
Market Cap: $162.416K info
NIVF
Sep 28, 2026, 10:30 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.340
Real-time Price: $0.1403 info
Change: -$0.1997 (-59%) info
Market Cap: $162.416K info
NIVF
Sep 10, 2026, 4:33 PM EDT
Filing Type: F-1/A
Importance Score:
8
Price at Filing: $1.12
Real-time Price: $0.1403 info
Change: -$0.9797 (-87%) info
Market Cap: $162.416K info
NIVF
Sep 02, 2026, 8:01 AM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $1.36
Real-time Price: $0.1403 info
Change: -$1.22 (-90%) info
Market Cap: $162.416K info
NIVF
Sep 01, 2026, 4:37 PM EDT
Filing Type: F-1/A
Importance Score:
7
Price at Filing: $1.35
Real-time Price: $0.1403 info
Change: Reverse Stock Split info
Market Cap: $162.416K info